Genomic evolution, antimicrobial resistance, and dissemination of global Serratia spp. unveil increasing species diversity and carbapenemae‑resistance: A retrospective and genomic epidemiology study

<i>Serratia</i> spp., an opportunistic pathogen, has increasingly acquired resistance, particularly the emergence of carbapenemase-resistance. However, previous studies have focused on fragmented surveillance and have not conducted overall correlation. Here, 3769 non-duplicate <i>Serratia</i> genomes from sixty-five different countries across seven continents were classified into thirty-seven bacterial species, with 14 novel genospecies. The most common species was <i>S. sarumanii</i>, followed by <i>S. nevei</i> and <i>S. marcescens</i>. 809 novel STs were determined, which was more than double the number of known STs, with ST 367 and ST324 being the most predominant. 26.6 % (1001/3769) of <i>Serratia</i> isolates were carbapenemase-resistant. These resistant isolates were first identified in 1970, sporadically detected before 2010, and have increased rapidly since 2011. Carbapenemase-resistant isolates were found in 46 countries, with the most prevalent being in the USA (41.2 %), China (9.9 %), Australia (7.6 %). 34 carbapenemase-encoding genes were reported, with the most common being <i>bla</i> <sub>KPC-2</sub> (25.7 %), <i>bla</i> <sub>SPR-1</sub> (19.2 %), <i>bla</i> <sub>KPC-3</sub> (10.1 %). 94 potential transmission events were identified from 24 countries, including five cross-country events. The largest epidemic clone of 99 isolates (ST324) was detected in USA, with longest lasting transmission event spanning 17 years and involving 15 isolates (ST893) from Australia. The overall incidence of MDR isolates was 61.6 %. The prevalence of carbapenemase genes associated with specific STs. 248 IS types and 61 plasmid replicons were identified in carbapenemase-resistant <i>Serratia</i> isolates, with varied IS or plasmid replicons being responsible for the spread of different carbapenemase genes. This comprehensive genomic study offers valuable insights into the population dynamics, prevalence and distribution of <i>Serratia</i>.

Authors

Institutions

Publication Details

Journal
Current Research in Microbial Sciences
Published
2025-01-01
DOI
https://doi.org/10.1016/j.crmicr.2025.100456
Citations
1
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Genomic evolution, antimicrobial resistance, and dissemination of global Serratia spp. unveil increasing species diversity and carbapenemae‑resistance: A retrospective and genomic epidemiology study

Hong Shen, Ming Hui Wei, Wentao Zhu, Xi Chen et al.
1 citations
Current Research in Microbial Sciences
Antibiotic Resistance in Bacteria
0.59
article

Genomic evolution, antimicrobial resistance, and dissemination of global Serratia spp. unveil increasing species diversity and carbapenemae‑resistance: A retrospective and genomic epidemiology study

Hong Shen, Ming Hui Wei, Wentao Zhu, Xi Chen, Li Gu, Qian Liu
article en
1 citations

Abstract

<i>Serratia</i> spp., an opportunistic pathogen, has increasingly acquired resistance, particularly the emergence of carbapenemase-resistance. However, previous studies have focused on fragmented surveillance and have not conducted overall correlation. Here, 3769 non-duplicate <i>Serratia</i> genomes from sixty-five different countries across seven continents were classified into thirty-seven bacterial species, with 14 novel genospecies. The most common species was <i>S. sarumanii</i>, followed by <i>S. nevei</i> and <i>S. marcescens</i>. 809 novel STs were determined, which was more than double the number of known STs, with ST 367 and ST324 being the most predominant. 26.6 % (1001/3769) of <i>Serratia</i> isolates were carbapenemase-resistant. These resistant isolates were first identified in 1970, sporadically detected before 2010, and have increased rapidly since 2011. Carbapenemase-resistant isolates were found in 46 countries, with the most prevalent being in the USA (41.2 %), China (9.9 %), Australia (7.6 %). 34 carbapenemase-encoding genes were reported, with the most common being <i>bla</i> <sub>KPC-2</sub> (25.7 %), <i>bla</i> <sub>SPR-1</sub> (19.2 %), <i>bla</i> <sub>KPC-3</sub> (10.1 %). 94 potential transmission events were identified from 24 countries, including five cross-country events. The largest epidemic clone of 99 isolates (ST324) was detected in USA, with longest lasting transmission event spanning 17 years and involving 15 isolates (ST893) from Australia. The overall incidence of MDR isolates was 61.6 %. The prevalence of carbapenemase genes associated with specific STs. 248 IS types and 61 plasmid replicons were identified in carbapenemase-resistant <i>Serratia</i> isolates, with varied IS or plasmid replicons being responsible for the spread of different carbapenemase genes. This comprehensive genomic study offers valuable insights into the population dynamics, prevalence and distribution of <i>Serratia</i>.

Current Research in Microbial SciencesVol. 9
Capital Medical University (CN), Beijing Chao-Yang Hospital, Capital Medical University (CN), Beijing Anzhen Hospital (CN)
Openalex Percentile: Top 32%
Antibiotic Resistance in Bacteria
0.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.